为防止转移而进行的集中监控减少了对受控物质的差异
概括
一个新的集中监测团队通过减少差异和加强监管合规性,迅速改善了受控物质 (CS) 管理. 这一举措在第一年内显著减少了明显的毒品损失,并改善了问责制.
科学领域:
- 医疗保健管理的管理
- 药房实践 在药房实践中
- 监管合规性 监管合规性
背景情况:
- 控制物质 (CS) 管理对于遵守法规,防止转移和确保患者安全至关重要.
- 制定一个全面的CS转移预防计划 (CSDPP) 是耗时且资源密集的.
- 现有的转移管理软件 (DMS) 实现面临不一致差异调和的挑战,导致严重的积压.
研究的目的:
- 快速解决受控物质变异问题,作为全面CSDPP发展的第一步.
- 建立一个具有成本效益的,集中的多学科团队来监测CS差异.
- 加强监管合规性,并促进CS管理实践.
主要方法:
- 在12个急性护理机构中使用了转移管理软件 (DMS).
- 实施了一个集中的多学科团队,每天审查CS差异.
- 实施前和实施后的数据对明显损失差异,药物处置责任和监管机构联系进行了比较.
主要成果:
- 在创建团队的三个月内实现了100%的CS差异审查.
- 在一年内减少了41%的明显损失差异.
- 对药物处置的问责制从62%提高到93%,监管报告减少了41%.
结论:
- 中央监控CS差异在六个月内产生了显著的好处,包括减少明显的损失和改善合规性.
- 这种基本方法建立了一个扩展全面的CSDPP的结构.
- 加强监测有效地解决了CS管理和监管要求的关键方面.
相关概念视频
Therapeutic Drug Monitoring: Overview and Classification
315
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
315
Therapeutic Drug Monitoring: Drug Analysis Methods
181
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
181
Drug Control Governance: Regulatory Bodies and Their Impact
497
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
497
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K


